ポリオワクチンの世界市場2018-2022

◆英語タイトル:Global Polio Vaccines Market 2018-2022
◆商品コード:IRTNTR23970
◆発行会社(リサーチ会社):Technavio
◆発行日:2018年10月11日
◆ページ数:96
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥374,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥535,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

ポリオは、ピコルナウイルス科ヒトエンテロウイルスによって引き起こされる伝染性の高い疾患であり、麻痺または死亡をもたらします。ポリオワクチンにはOPVとIPVの2種類があります。感染に対する予防接種が世界的に政府の取り組みによって推進されているため、ポリオの発生率は減少しています。ポリオワクチンの世界市場は、2018~2022年の間、年平均成長率17.65%で成長すると予測されています。

主な分析対象企業は、Astellas Pharma、GlaxoSmithKline、Sanofi、Serum Institute of Indiaなどです。

当調査レポートでは、ポリオワクチンの世界市場について調査・分析し、市場概要、市場環境、ポリオワクチン市場規模、ワクチンの種類別(OPV、IPV)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。

・エグゼクティブサマリー
・調査範囲・調査手法
・ポリオワクチンの世界市場概要
・ポリオワクチンの世界市場環境
・ポリオワクチンの世界市場動向
・ポリオワクチンの世界市場規模
・ポリオワクチンの世界市場:業界構造分析
・ポリオワクチンの世界市場:ワクチンの種類別(OPV、IPV)
・ポリオワクチンの世界市場:地域別市場規模・分析
・ポリオワクチンの北米市場規模・予測
・ポリオワクチンのヨーロッパ・中東・アフリカ市場規模・予測
・ポリオワクチンのアジア太平洋市場規模・予測
・ポリオワクチンの主要国分析
・ポリオワクチンの世界市場:意思決定フレームワーク
・ポリオワクチンの世界市場:成長要因、課題
・ポリオワクチンの世界市場:競争環境
・ポリオワクチンの世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About Polio
Polio is a highly contagious disease caused by a human enterovirus of the Picornaviridae family, resulting in paralysis or death. Two types of polio vaccination are available, OPV and IPV. The incidence of polio has been decreasing owing to initiatives by governments globally to drive immunization against the infection.
Technavio’s analysts forecast the Global Polio Vaccines Market to grow at a CAGR of 17.65% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the polio vaccines market. To calculate the market size, the report considers the revenue generated from the retail sales of polio vaccines across the globe.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, polio vaccines market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Astellas Pharma
• GlaxoSmithKline
• Sanofi
• Serum Institute of India
Market driver
• Increased funding for the development of various types of polio vaccine
• For a full, detailed list, view our report

Market challenge
• Lack of effective cold chain logistic
• For a full, detailed list, view our report

Market trend
• Cessation of oral polio vaccine
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: PIPELINE ANALYSIS
• Pipeline analysis
PART 06: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 08: MARKET SEGMENTATION BY VACCINE TYPE
• Segmentation by vaccine type
• Comparison by vaccine type
• OPV – Market size and forecast 2017-2022
• IPV – Market size and forecast 2017-2022
• Market opportunity by vaccine type
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Cessation of oral polio vaccine
• Ensuring vaccination in conflict zones and countries with weak health systems
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Astellas Pharma
• GlaxoSmithKline
• Sanofi
• Serum Institute of India
PART 16: APPENDIX
• List of abbreviations



Exhibit 01: Parent market
Exhibit 02: Global human vaccines market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Pipeline drugs under phase III development
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2017
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global polio vaccines market – Market size and forecast 2017-2022 ($ mn)
Exhibit 10: Global polio vaccines market – Year over year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition – Five forces 2017
Exhibit 19: Global polio vaccines market by vaccine type – Market share 2017-2022 (%)
Exhibit 20: Comparison by vaccine type
Exhibit 21: Global polio vaccines market by OPV – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Global polio vaccines market by OPV – Year over year growth 2018-2022 (%)
Exhibit 23: Global polio vaccines market by IPV – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Global polio vaccines market by IPV – Year over year growth 2018-2022 (%)
Exhibit 25: Market opportunity by vaccine type
Exhibit 26: Customer landscape
Exhibit 27: Global polio vaccines market by region – Market share 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Polio vaccines market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Polio vaccines market in Americas – Year over year growth 2018-2022 (%)
Exhibit 31: Top three countries in Americas
Exhibit 32: Polio vaccines market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Polio vaccines market in EMEA – Year over year growth 2018-2022 (%)
Exhibit 34: Top three countries in EMEA
Exhibit 35: Polio vaccines market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: Polio vaccines market in APAC – Year over year growth 2018-2022 (%)
Exhibit 37: Top three countries in APAC
Exhibit 38: Market opportunity
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Astellas Pharma overview
Exhibit 45: Astellas Pharma – Business segments
Exhibit 46: Astellas Pharma – Organizational developments
Exhibit 47: Astellas Pharma – Geographic focus
Exhibit 48: Astellas Pharma – Key offerings
Exhibit 49: GlaxoSmithKline overview
Exhibit 50: GlaxoSmithKline – Business segments
Exhibit 51: GlaxoSmithKline – Organizational developments
Exhibit 52: GlaxoSmithKline – Geographic focus
Exhibit 53: GlaxoSmithKline – Segment focus
Exhibit 54: GlaxoSmithKline – Key offerings
Exhibit 55: Sanofi overview
Exhibit 56: Sanofi – Business segments
Exhibit 57: Sanofi – Organizational developments
Exhibit 58: Sanofi – Geographic focus
Exhibit 59: Sanofi – Segment focus
Exhibit 60: Sanofi – Key offerings
Exhibit 61: Serum Institute of India overview
Exhibit 62: Serum Institute of India – Business segments
Exhibit 63: Serum Institute of India – Organizational developments
Exhibit 64: Serum Institute of India – Key offerings



【掲載企業】

Astellas Pharma、GlaxoSmithKline、Sanofi、Serum Institute of India

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ポリオワクチンの世界市場2018-2022]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆